A. Hovhannesyan

Diagnostic Procedures, Diagnoses, and Treatment Outcomes of Patients with Presumptive Tuberculosis Pleural Effusion in Uzbekistan

N. Tukvadze, A. Dadu, J. Gadoev, 2021, International journal of environmental research and public health.

Effectiveness and safety of fully oral modified shorter treatment regimen for multidrug-resistant tuberculosis in Georgia, 2019–2020

N. Tukvadze, H. Davtyan, O. Denisiuk, 2021, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

Alarming levels of multidrug-resistant tuberculosis in Ukraine: results from the first national survey.

D. Cirillo, M. Dara, M. Zignol, 2018, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Time to start of tuberculosis treatment in penitentiary system of Kyrgyz Republic: A retrospective cohort study

R. Rossi, A. Hovhannesyan, Nazgul Soltobekova, 2022, PloS one.

Social determinants and risk factors for tuberculosis in national surveillance systems in Europe.

P. de Colombani, A. Hovhannesyan, 2015, Public health action.

Behavior change communication model enhancing parental practices for improved early childhood growth and development outcomes in rural Armenia – A quasi-experimental study

A. Hovhannesyan, V. Sargsyan, A. Rosales, 2019, Preventive medicine reports.

Characteristics and Treatment Outcomes of Patients with Tuberculosis Receiving Adjunctive Surgery in Uzbekistan

A. Ciobanu, J. Gadoev, N. Parpieva, 2021, International journal of environmental research and public health.

Incidence Rate and Risk Factors for Tuberculosis among People Living with HIV: A 2015–2017 Cohort from Tashkent, Uzbekistan

N. Tukvadze, A. Dadu, J. Gadoev, 2021, International journal of environmental research and public health.

Delays and associated risk factors, in the detection and treatment of rifampicin-resistant tuberculosis patients in Ukraine

O. Denisiuk, A. Hovhannesyan, O. Korotych, 2019 .

Effectiveness and Safety of a Shorter Treatment Regimen in a Setting with a High Burden of Multidrug-Resistant Tuberculosis

A. Ciobanu, J. Gadoev, N. Parpieva, 2021, International journal of environmental research and public health.

Time to sputum conversion in multidrug-resistant tuberculosis patients in Armenia: retrospective cohort study

E. Breeze, B. Crape, A. Hovhannesyan, 2012 .

Incidence rate and time to serious adverse events among rifampicin resistant tuberculosis patients in Georgia treated with new and repurposed anti-tuberculosis drugs, 2016–2018

H. Davtyan, O. Denisiuk, Yuliia Sereda, 2021, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

Drug-resistant tuberculosis in eastern Europe and central Asia: a time-series analysis of routine surveillance data.

M. Dara, M. J. van der Werf, A. Dadu, 2019, The Lancet. Infectious diseases.

Tuberculosis surveillance and monitoring in Europe 2012.

P. Zucs, C. Acosta, J. Beauté, 2012 .